Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCAY.L Regulatory News (CAY)

  • There is currently no data for CAY

Trading Update

24 Jul 2018 07:00

RNS Number : 4964V
Charles Stanley Group PLC
24 July 2018
 

 

24 July 2018

Charles Stanley Group PLC

 

Trading update for the three months ended 30 June 2018

 

Charles Stanley Group PLC ("Charles Stanley" or "the Group") today issues a trading update for the first quarter ended 30 June 2018.

 

Total Funds under Management and Administration ("FuMA") at 30 June 2018 were £24.9 billion representing an increase of 4.6% on the £23.8 billion at 31 March 2018. This increase was largely driven by positive market performance. Over the same period the MSCI WMA Private Investor Balanced Index rose by 4.5%.

 

The majority of the asset growth was registered in our higher margin Discretionary service, which increased by £0.7bn or 5.7%. Execution-only funds grew by 4.8% (£0.4bn) overall and Charles Stanley Direct, our on-line platform continued its strong progress, with funds under administration up 13.0% to £2.6bn. Advisory managed and advisory dealing fund categories remained relatively flat during the quarter.

 

Core Business revenues for YTD June 2018 were up 4.0% from £37.7 million to £39.2 million compared to the quarter ended 30 June 2017.

 

Paul Abberley, Chief Executive Officer of Charles Stanley, said: "I am pleased to report that trading conditions in Q1 were in line with our expectations. We remain focused, as outlined in our 2018 year-end results, on the execution of our strategy to deliver top line growth and to streamline our operating model."

 

 

For further information, please contact: 

 

 Charles Stanley

 Joanne Higginson

 Public Relations Manager

 Via Redleaf

 Canaccord Genuity

Simon Bridges

020 7523 8000

 Peel Hunt

 Guy Wiehahn

 020 7418 8893

 Newgate Communications

 Adam Lloyd

 020 7653 9842

 CScapitalmarkets@redleafpr.com

 

Notes to editors:

 

Charles Stanley traces its origins back directly to 1792 and is one of the oldest firms on the London Stock Exchange. Charles Stanley today provides holistic wealth management services to private clients, charities and smaller institutions. These are delivered by over 400 professionals located in 22 offices throughout the UK, both direct to clients and to intermediaries. Our services include investment portfolio management and financial planning, supported by in-house administration to enhance the quality of service provided. In addition, Charles Stanley Direct provides an award winning direct to customer execution-only dealing platform for equities and funds.

 

FUNDS UNDER MANAGEMENT AND ADMINISTRATION

 

 

Change

Jun 18

Mar 18

since

£bn

£bn

Mar 18

Discretionary funds

13.0

12.3

5.7%

Advisory managed funds

1.8

1.8

-

Total managed funds

14.8

14.1

5.0%

Advisory dealing funds

1.4

1.4

-

Execution only funds

8.7

8.3

4.8%

Total administered funds

 10.1

9.7

4.1%

Total FuMA

24.9

23.8

4.6%

MSCI WMA Private Investor Balanced Index

1,597

1,527

4.5%

 

 

The change in managed funds since 31 March 2018 is explained in more detail in the table below:

 

 

Discretionary managed

Advisory managed

Advisory dealing

Execution-only

 

Total

£bn

£bn

£bn

£bn

£bn

Funds at 1 April 2018

12.3

1.8

1.4

8.3

23.8

New clients

0.2

-

-

0.1

0.3

Transfers

0.1

(0.1)

-

-

-

Net inflow/(outflow) from existing clients

(0.1)

-

-

-

(0.1)

Lost clients

(0.1)

-

-

(0.1)

(0.2)

Net inflow/(outflow) of funds

0.1

(0.1)

-

-

-

Market movement

0.6

0.1

-

0.4

1.1

Funds at 30 June 2018

13.0

1.8

1.4

8.7

24.9

 

 

 

 

REVENUE

 

The table below sets out the revenues of the Group for the quarter ended 30 June 2018 along with the prior year comparatives on a like for like basis.

 

 

Quarter ended 30 June 2018

 

Investment Management Services

 

Asset Management

 

Financial Planning

Charles Stanley Direct

 

Core Business

Held For Sale

 

 

Total

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Fee income

23,061

1,557

1,651

764

27,033

-

27,033

Commission

9,816

265

3

402

10,486

-

10,486

Interest income

1,148

11

-

499

1,658

-

1,658

Total

34,025

1,833

1,654

1,665

39,177

-

39,177

Quarter ended 30 June 2017

 

Investment Management Services2

 

Asset Management1

 

Financial Planning

Charles Stanley Direct

 

Core Business

Held For Sale

 

 

Total

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Fee income

21,575

1,438

1,299

564

24,876

542

25,418

Commission

11,452

207

11

376

12,046

-

12,046

Interest income

433

6

-

356

795

-

795

Total

33,460

1,651

1,310

1,296

37,717

542

38,259

1The increase in interest income during the quarter ended 30 June 2018 compared to the same quarter last year is due to higher interest rates and a change in the duration profile of cash levels placed on deposit.

 

2The revenue figures for the quarter ended 30 June 2017 have been restated to reflect the transfer of an investment management team from Asset Management to Investment Management Services during 2018. Held For Sale revenues for the quarter ended 30 June 2017 were in respect of EBS Management PLC, which was disposed of by the Group on 31 May 2017.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTEXLFLVDFZBBV
Date   Source Headline
26th Jul 201811:17 amRNSHolding(s) in Company
25th Jul 20183:26 pmRNSHolding(s) in Company
24th Jul 20181:01 pmRNSResult of AGM
24th Jul 20187:00 amRNSTrading Update
23rd Jul 20182:56 pmRNSHolding(s) in Company
20th Jul 20182:39 pmRNSHolding(s) in Company
13th Jul 20182:55 pmRNSDirector/PDMR Shareholding
10th Jul 20184:21 pmRNSHolding(s) in Company
6th Jul 20184:25 pmRNSHolding(s) in Company
5th Jul 20183:38 pmRNSBlock listing Interim Review
3rd Jul 20183:26 pmRNSDirector/PDMR Shareholding
3rd Jul 20183:22 pmRNSDirector/PDMR Shareholding
3rd Jul 201812:44 pmRNSHolding(s) in Company
29th Jun 20182:29 pmRNSTotal Voting Rights
25th Jun 20184:17 pmRNSAnnual Financial Report
13th Jun 201812:13 pmRNSCorrection to Financial Calendar
13th Jun 20187:01 amRNSBoard Committee Changes
13th Jun 20187:00 amRNSFinal Results
12th Jun 20189:21 amRNSDirector/PDMR Shareholding
7th Jun 20181:56 pmRNSHolding(s) in Company
5th Jun 201810:26 amRNSHolding(s) in Company
31st May 20183:48 pmRNSTotal Voting Rights
23rd May 201810:57 amRNSHolding(s) in Company
18th May 20185:06 pmRNSHolding(s) in Company
14th May 201811:25 amRNSDirector/PDMR Shareholding
11th May 201811:27 amRNSHolding(s) in Company
10th May 20189:12 amRNSDirector Declaration
2nd May 20185:03 pmRNSHolding(s) in Company
30th Apr 201812:13 pmRNSHolding(s) in Company
24th Apr 20184:17 pmRNSHolding(s) in Company
18th Apr 201812:41 pmRNSDirector/PDMR Shareholding
16th Apr 20187:25 amRNSFuMA Update and Notice of Results
29th Mar 20184:03 pmRNSTotal Voting Rights
28th Mar 20183:41 pmRNSHolding(s) in Company
28th Mar 20183:36 pmRNSHolding(s) in Company
22nd Mar 20184:47 pmRNSHolding(s) in Company
22nd Mar 20181:52 pmRNSHolding(s) in Company
13th Mar 20182:13 pmRNSDirector/PDMR Shareholding
28th Feb 20182:36 pmRNSTotal Voting Rights
13th Feb 20181:24 pmRNSHolding(s) in Company
13th Feb 201811:39 amRNSDirector/PDMR Shareholding
6th Feb 201812:34 pmRNSHolding(s) in Company
31st Jan 20181:20 pmRNSTotal Voting Rights
29th Jan 20183:38 pmRNSTR-1
23rd Jan 20187:00 amRNSTrading Update
22nd Jan 20189:13 amRNSDirector/PDMR Shareholding
17th Jan 20181:50 pmRNSAdditional Listing
15th Jan 20182:22 pmRNSDirector/PDMR Shareholding
28th Dec 201712:32 pmRNSTotal Voting Rights
20th Dec 20173:25 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.